Approval · Notice of Compliance 33772 · 2024
SENSORCAINE: Notice of Compliance 33772
Issued August 7, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33772
- Date
- August 7, 2024
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production. Addition of a drug product manufacturing site and/or manufacturer involving primary packaging. Change in the batch size for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE | Not yet assigned | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML